Top Markets
Coin of the day
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Rangering i aksjer #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Aksjekurs
$0.01904982
Sist synkronisert: 2023-05-19
Markedsverdi
$316.00K
Endring (1 dag)
-17.05%
Endring (1 år)
0.00%
Land
GB
Handel OKYO Pharma Limited (OKYO)

Kategori

Utbyttehistorikk for OKYO Pharma Limited (OKYO)
OKYO Pharma Limited (aksjesymbol: OKYO) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for OKYO Pharma Limited (OKYO) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE